| Nov 12 |
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
|
| Nov 5 |
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
|
| Oct 12 |
Turnstone Biologics Streamlines Operations and Leadership
|
| Oct 11 |
FDA clears Roche breast cancer drug; Turnstone lays off 60% of staff
|
| Oct 11 |
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
|
| Aug 15 |
Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
|
| Aug 15 |
Dow Surges Over 500 Points; US Retail Sales Rise In July
|
| Aug 14 |
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
|
| Aug 14 |
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
|
| Aug 12 |
Turnstone Biologics Corp. (TSBX): This Penny Stock is a ‘Strong Buy’ According to Analysts
|
